AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2010
Mar 8, 2010
32566_dirs_2010-03-08_23059b67-014a-450b-956c-4e92e45241c9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2010-03-08
Reporting Person: MELDRUM PETER D (Director, President & C.E.O.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2010-03-08 | Common Stock | M | 30754 | $8.86 | Acquired | 232583 | Direct |
| 2010-03-08 | Common Stock | S | 30754 | $22.3014 | Disposed | 201829 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2010-03-08 | Non-Qualified Stock Option (right to buy) | $8.86 | M | 30754 | Disposed | 2010-04-20 | Common Stock (30754) | Direct |
Footnotes
F1: 20% vests annually beginning on the 1st anniversary of the date of the Option Grant.
More from MYRIAD GENETICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
Jun 4
Share Issue/Capital Change
2026
Jun 4
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27